Analyst picks & changes

Vertex Pharmaceuticals Inc.

(VRTX)

Robertson, Stephens analyst Michael Walsh initiated coverage with a "strong buy." Within three years, Walsh said, the

Read the full 212 word article

How to gain access

Continue reading with a
two-week free trial.